{"groups":[{"description":"Medical therapy with Octreotide LAR 30 mg/month for 3 months preceding surgery\n\nOctreotide LAR","id":"FG000","title":"Medical Treatment by Octreotide LAR"},{"description":"Surgical debulking of pituitary tumor followed by Octreotide LAR if not surgically cured\n\nOctreotide LAR\n\ntranssphenoidal surgery","id":"FG001","title":"Surgical Debulking Followed by Octreotide LAR"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"}],"type":"Withdrawal by Subject"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"26"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"26"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}